Favorite  |  Set Home
Product name : AGI-6780
Item : CR1781
Price : 200mg, $659;500mg, $1150; 1g, $1595; 2g, $2355
contact : Send inquiry to: info@acesobio.com
CAS : 1432660-47-3
Molecular Weight : 481.51
Formula : C₂₁H₁₈F₃N₃O₃S₂
Storage : at -20°C
Additional information :  We offer significant discount for bulky quantity order,Please ask price and availability of other quantities
 Enlarge Image                   Back

 Chemical Information
M.Wt 481.51 Storage Please store the product under the recommended conditions in the Certificate of Analysis.
Formula C21H18F3N3O3S2
CAS No 1432660-47-3


Biological Activity of AGI-6780


AGI-6780 is the first highly potent and selective small molecule inhibitor of isocitrate dehydrogenases, which binds in an allosteric manner at the dimer interface of mutant IDH2-R140Q (IC50=23 nM).
IC50 Value: 23 nM (IDH2-R140Q) [1]
Target:  mutant IDH2-R140Q
in vitro: AGI-6780 inhibits IDH2-R140Q in vitro with an IC50 ~23 nM and inhibits 2-HG formation in human glioblastoma U87 and TF-1 cells expressing IDH2-R140Q with IC50 < 20 nM. AGI-6780 can reverse the differentiation blockade in TF-1 cells conferred by IDH2-R140Q, and induce blast differentiation in primary human IDH2-R140Q AML patient samples. It provides proof-of-concept that inhibitors targeting mutant IDH2-R140Q could have potential applications as a differentiation therapy for cancer [1].
in vivo: N/A
Toxicity: N/A
Clinical trial: Phase I Study of AG-221 in Subjects With Advanced Hematological Malignancies With an IDH2 Mutation. Phase 1


Clinical Information of AGI-6780


[1]. Wang F, et al. Targeted inhibition of mutant IDH2 in leukemia cells induces cellular differentiation. Science. 2013 May 3;340(6132):622-6.

Related Products :